BUCHAREST (Romania), March 10 (SeeNews) – Market research company IMS Health sees Romania's drug market rising 7.4% this year, slower than the 16% growth in 2010, due to a deteriorated performance of the hospital segment, payment delays and higher debts in the system, local news portal Wall-street.ro reported on Thursday.